How mazdutide compares to semaglutide Mazdutide has been directly compared to semaglutide in the DREAMS-3 head-to-head trial
Who should avoid Wegovy
Fayyad-Kazan M, Feller A, Bodo E, Boeckstaens M, Marini AM, Dubois E, et al
Sikiric P, Petek M, Rucman R, et al
Around 50,000 eligible patients in England could be prescribed Wegovy through NHS specialist weight management services, that are able to provide appropriate multidisciplinary care. The move follows a five-year study by Novo Nordisk, known as the Select trial, which found the drug could cut the risk of a heart attack or stroke in obese people with cardiovascular disease by a fifth
Semaglutide cyanocobalamin formulations are typically injectable